Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience
- 1 November 2003
- journal article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 11 (11) , 722-727
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignanciesBlood, 2002
- Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent FeverNew England Journal of Medicine, 2002
- Long-term follow-up and outcome of 39 patients with chronic granulomatous diseaseThe Journal of Pediatrics, 2000
- New Drugs and Novel Targets for Treatment of Invasive Fungal Infections in Patients with CancerThe Oncologist, 2000
- Aspergillosis in Children with Cancer: A 34-Year ExperienceClinical Infectious Diseases, 1999
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infectionsBritish Journal of Haematology, 1998
- A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patientsBritish Journal of Haematology, 1997
- Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.Journal of Clinical Oncology, 1997
- Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and ReviewClinical Infectious Diseases, 1992